Nutri Pharmaceuticals Research, Inc. (NRPR)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0200 (-44.44%)
At close: Jun 11, 2025

NRPR Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2003 FY 2002
Period Ending
Sep '04 Dec '03 Dec '02
Net Income
-0.47-0.16-0.01
Depreciation & Amortization
0.040.010
Other Operating Activities
0.220.1-
Change in Accounts Receivable
-0.02-0-
Change in Accounts Payable
0.140.03-
Change in Unearned Revenue
0.020.03-
Change in Other Net Operating Assets
0.050.03-
Operating Cash Flow
0.020.03-0
Capital Expenditures
-0.03--0
Investing Cash Flow
-0.01--0
Short-Term Debt Issued
-0-
Total Debt Issued
0.030-
Long-Term Debt Repaid
--0.01-
Net Debt Issued (Repaid)
-0.01-0.01-
Issuance of Common Stock
0.070.06-
Other Financing Activities
---0
Financing Cash Flow
0.060.06-0
Net Cash Flow
0.070.09-0.01
Free Cash Flow
-0.010.03-0.01
Free Cash Flow Margin
-0.77%27.34%-
Free Cash Flow Per Share
-0.010.36-0.07
Cash Interest Paid
0.010-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.